Charming Medical Limited (MCTA)
NASDAQ: MCTA · Real-Time Price · USD
29.11
-0.25 (-0.83%)
Nov 11, 2025, 4:00 PM EDT - Market closed

Charming Medical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Nov '25 Mar '26 Mar '25 Mar '24 Mar '23
504504---
Market Cap Growth
-----
Enterprise Value
502502---
Last Close Price
-29.36---

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Nov '25 Mar '26 Mar '25 Mar '24 Mar '23
PS Ratio
104.89104.89---
PB Ratio
97.3397.33---
P/TBV Ratio
97.3397.33---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Nov '25 Mar '26 Mar '25 Mar '24 Mar '23
EV/Sales Ratio
104.51104.45---
EV/EBITDA Ratio
1548.071547.05---
EV/EBIT Ratio
4630.754627.70---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Nov '25 Mar '26 Mar '25 Mar '24 Mar '23
Debt / Equity Ratio
0.180.1823.57-0.84-1.43
Debt / EBITDA Ratio
1.041.040.450.403.77
Debt / FCF Ratio
--8.3911.330.99
Net Debt / Equity Ratio
-1.31-1.31-36.191.250.09
Net Debt / EBITDA Ratio
-20.85-20.85-0.96-0.920.71
Net Debt / FCF Ratio
4.354.35-12.88-16.94-0.06
Asset Turnover
0.630.631.221.07-
Inventory Turnover
6.686.687.343.61-
Quick Ratio
1.821.820.680.470.55
Current Ratio
1.891.890.680.620.57
Return on Equity (ROE)
-0.87%-0.87%---
Return on Assets (ROA)
0.89%0.89%19.53%13.01%-
Return on Capital Employed (ROCE)
2.00%2.00%392.80%-117.50%48.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period Ending
Nov '25 Mar '26 Mar '25 Mar '24 Mar '23
Earnings Yield
-0.00%-0.00%---
FCF Yield
-0.31%-0.31%---
Buyback Yield / Dilution
-5.29%-5.29%---
SEC Filings: 10-K · 10-Q